Exelixis Inc. Common Stock vs MKS Instruments — how do they compare? Exelixis Inc. Common Stock trades at $60.43 (market cap $14.62B), while MKS Instruments trades at $262.86 (market cap $17.61B). The key difference: MKS Instruments is the larger of the two by market cap, and MKS Instruments pays a 0.38% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and MKS Instruments for 7 Days on average.
| EXEL | MKSI | |
|---|---|---|
Market Cap | $14.62B | $17.61B |
Volume | 2,684,957 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $59.13 | $444.80 |
52-Week Low | $34.54 | $121.26 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $13.95B | $21.18B |
Dividend Yield | — | 0.38% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →